Related Experiment Video

Updated: Aug 7, 2026

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
12:49

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Published on: March 21, 2020

PARK8 LRRK2 parkinsonism

Kristoffer Haugarvoll, Zbigniew K Wszolek

    Current Neurology and Neuroscience Reports
    |July 11, 2006
    PubMed

    Insights

    Parkinson's disease (PD) is a common neurodegenerative disorder. Recent discoveries highlight leucine-rich repeat kinase 2 (LRRK2) gene mutations as a key factor in understanding parkinsonism, though treatments halting progression are still lacking.

    Area of Science:

    • Neuroscience
    • Genetics
    • Neurology

    Background:

    • Parkinson's disease (PD) is the most prevalent form of parkinsonism, impacting approximately 2% of individuals over 65.
    • Current treatments for PD offer symptomatic relief but do not impede disease progression.
    • Genetic research has identified several causative genes for familial parkinsonism, including the leucine-rich repeat kinase 2 (LRRK2) gene.

    Purpose of the Study:

    • To review the current understanding of LRRK2 gene mutations in relation to parkinsonism.
    • To highlight the significance of LRRK2 in the genetic basis of Parkinson's disease.

    Main Methods:

    • Literature review of studies on LRRK2 mutations and parkinsonism.
    • Synthesis of current knowledge on the genetic contribution of LRRK2 to PD.

    Main Results:

    • Pathogenic mutations in the LRRK2 gene are a significant cause of clinically typical, late-onset PD.
    • LRRK2 mutations represent a crucial area of research in understanding the genetic underpinnings of parkinsonism.

    Conclusions:

    • LRRK2 mutations play a substantial role in the etiology of a considerable proportion of Parkinson's disease cases.
    • Further research into LRRK2 is essential for developing disease-modifying therapies for parkinsonism.

    More Related Videos

    Assaying the Kinase Activity of LRRK2 in vitro06:09

    Assaying the Kinase Activity of LRRK2 in vitro

    Published on: January 18, 2012

    Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag08:55

    Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

    Published on: December 14, 2017

    Related Concept Videos

    Parkinson Disease l: Introduction01:24

    Parkinson Disease l: Introduction

    Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
    Parkinson Disease ll: Pathophysiology01:24

    Parkinson Disease ll: Pathophysiology

    Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
    Parkinson's Disease: Overview01:15

    Parkinson's Disease: Overview

    Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
    Parkinson's Disease: Treatment01:24

    Parkinson's Disease: Treatment

    Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
    Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
    Alterations in Muscle Tone lll01:11

    Alterations in Muscle Tone lll

    Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
    Neural Regulation01:37

    Neural Regulation

    Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.